tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate

Catalog No. :
ACHEXS820
CAS No. :
1148044-31-8
Molecular Formula :
C11H20N2O2
Molecular Weight :
212.29

IUPAC Name:tert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate

tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$101.00Login to see priceIn stockInquiry
100mg98%$145.00Login to see priceIn stockIn stock
250mg98%$269.00Login to see priceIn stockIn stock
1g98%$673.00Login to see priceIn stockIn stock
5g98%$3298.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate
IUPAC Nametert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate
MDL No.MFCD12406507
Molecular FormulaC11H20N2O2
Molecular Weight212.29
SMILESO=C(N1CCC12CNCC2)OC(C)(C)C
InChI KeyOJDKDBHLSUSOBW-UHFFFAOYSA-N
Synonym1,6-Diaza-spiro[3.4]octane-1-carboxylic acid tert-butyl ester;1-N-Boc-1,6-diaza-spiro[3.4]octane;1,6-Diazaspiro[3.4]octane-1-carboxylic acid, 1,1-diMethylethyl ester;tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate;1-Boc-1,6-Diazaspiro[3.4]octane;tert-butyl 1,7-diazaspiro[3.4]octane-1-carboxylate
CAS No.1148044-31-8
PubChem CID56962149

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACHEXS820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHEXS820 route product structure diagram
    ACHEXS8201148044-31-8 In Stock
Inquiry

2. ACHEXS820 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHEXS820 route product structure diagram
    ACHEXS8201148044-31-8 In Stock
Inquiry

Comments (0)